8-K: TerrAscend Reports Strong Q2 2024 Results with Revenue Growth and Increased Profitability

Sentiment:

Quarterly Report


TerrAscend Corp. announced a 7.5% year-over-year increase in net revenue to $77.5 million and a significant improvement in profitability for the second quarter of 2024.

Capital raiseTerrAscend closed on a senior secured term loan for gross proceeds of $140 million.The loan has an interest rate of 12.75% and matures in August 2028.The initial draw of $114 million was used to retire existing debt in Pennsylvania and for potential M&A.A second draw of $26 million is expected in September 2024 to retire debt in Michigan.
Better than expectedThe company's net loss improved significantly compared to the same quarter last year.EBITDA and Adjusted EBITDA showed substantial year-over-year growth.The company generated positive free cash flow, a significant improvement from the previous year.

Summary

  • TerrAscend reported a net revenue of $77.5 million for Q2 2024, a 7.5% increase compared to $72.1 million in Q2 2023.
  • The company's gross profit margin was 48.6%, slightly down from 50.2% in the same quarter last year.
  • GAAP net loss from continuing operations improved to $6.2 million, compared to a $12.9 million loss in Q2 2023.
  • EBITDA from continuing operations saw a substantial increase of 186% year-over-year, reaching $18.6 million.
  • Adjusted EBITDA from continuing operations grew by 21.9% year-over-year to $15.6 million, with a margin of 20.2%.
  • Net cash provided by continuing operations was $13.1 million, a significant increase from $1.8 million in Q2 2023.
  • Free cash flow was $11.7 million, compared to a negative $0.2 million in the same period last year.
  • The company secured a $140 million term loan to support its growth strategy.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial improvements, strategic growth initiatives, and a significant capital raise. While there are some challenges, the overall tone is optimistic and indicates a company on a positive trajectory.

Positives

  • TerrAscend achieved its eighth consecutive quarter of positive cash flow from continuing operations.
  • The company significantly reduced its General & Administrative expenses as a percentage of revenue, from 42.3% to 31.1%.
  • The company received an $8.4 million federal tax refund.
  • The expansion of the Hagerstown, Maryland facility doubled its output capacity.
  • The $140 million term loan provides financial flexibility for future growth and acquisitions.
  • The company is actively pursuing multiple transactions to expand its geographic footprint.

Negatives

  • Gross profit margin decreased slightly from 50.2% to 48.6% year-over-year.
  • Retail revenue declined by 8.7% year-over-year, mainly driven by New Jersey and Michigan.
  • The company reported a net loss from continuing operations of $6.2 million, although this is an improvement from the previous year.

Risks

  • The cannabis industry faces significant legal restrictions and regulations in the United States.
  • Cannabis remains illegal under U.S. federal law, posing a risk to the company's operations.
  • Enforcement of federal laws in the United States is a significant risk to the business.
  • The company's future performance is subject to market conditions and regulatory changes.

Future Outlook

The company is focused on expanding its geographic footprint through strategic acquisitions and leveraging its recent $140 million term loan to fuel growth. They are closing in on multiple transactions to enter new states.

Management Comments

  • Jason Wild, Executive Chairman, stated that the company delivered another quarter of positive free cash flow.
  • Jason Wild also mentioned that the company has the right team, high-performing assets, and a major differentiation in having a wide open map.
  • Management is excited to share more details about expansion plans when appropriate.

Industry Context

The cannabis industry is experiencing growth and consolidation, with companies like TerrAscend focusing on expanding their presence in key markets. The company's focus on wholesale revenue growth and strategic acquisitions aligns with industry trends.

Comparison to Industry Standards

  • TerrAscend's 7.5% revenue growth is solid, but some competitors in the cannabis space have seen higher growth rates, particularly in newer markets.
  • The 186% increase in EBITDA is a strong performance, indicating improved operational efficiency compared to many peers.
  • The company's focus on free cash flow generation is a positive differentiator, as many cannabis companies struggle with profitability.
  • The #1 market share in New Jersey is a significant achievement, demonstrating strong brand recognition and market penetration.
  • Companies like Curaleaf and Trulieve, which are larger multi-state operators, have higher revenue but may not have the same level of free cash flow generation.
  • TerrAscend's expansion strategy through acquisitions is similar to other MSOs, but the company's focus on 'best in breed' operators could provide a competitive advantage.

Stakeholder Impact

  • Shareholders will likely view the improved financial results and strategic growth plans positively.
  • Employees may benefit from the company's expansion and increased stability.
  • Customers will continue to have access to a wide range of cannabis products.
  • Suppliers may see increased business opportunities as the company expands.
  • Creditors will be reassured by the company's improved cash flow and financial position.

Next Steps

  • The company will continue to pursue strategic acquisitions to expand its geographic footprint.
  • TerrAscend will utilize the proceeds from the $140 million term loan to fund growth initiatives.
  • The company will continue to focus on improving operational efficiency and profitability.
  • Management will provide further updates on expansion plans when appropriate.

Key Dates

DateDescription
September 30, 2023The date through which the Canadian licensed producer business is reported as discontinued operations.
December 31, 2023Date of the comparative balance sheet data.
March 31, 2024Date of the comparative cash and cash equivalents data.
June 30, 2024End of the second quarter for which financial results are reported.
August 7, 2024Date of share information provided.
August 8, 2024Date of the press release and conference call to discuss the results.
August 2028Maturity date of the $140 million term loan.

Keywords

cannabis, TerrAscend, financial results, revenue, EBITDA, cash flow, market share, wholesale, retail, term loan, expansion

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.